Ameritas Investment Partners’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8K | Buy |
7,349
+2,264
| +45% | +$14.7K | ﹤0.01% | 2210 |
|
|
2025
Q1 | $40.3K | Hold |
5,085
| – | – | ﹤0.01% | 2233 |
|
|
2024
Q4 | $64.4K | Hold |
5,085
| – | – | ﹤0.01% | 2036 |
|
|
2024
Q3 | $70.8K | Hold |
5,085
| – | – | ﹤0.01% | 1989 |
|
|
2024
Q2 | $70.1K | Sell |
5,085
-1,194
| -19% | -$16.5K | ﹤0.01% | 1952 |
|
|
2024
Q1 | $104K | Hold |
6,279
| – | – | ﹤0.01% | 1715 |
|
|
2023
Q4 | $91.7K | Hold |
6,279
| – | – | ﹤0.01% | 1794 |
|
|
2023
Q3 | $77K | Buy |
6,279
+2,213
| +54% | +$27.2K | ﹤0.01% | 1832 |
|
|
2023
Q2 | $48.5K | Buy |
4,066
+1,895
| +87% | +$22.6K | ﹤0.01% | 2070 |
|
|
2023
Q1 | $29K | Hold |
2,171
| – | – | ﹤0.01% | 2293 |
|
|
2022
Q4 | $47.3K | Hold |
2,171
| – | – | ﹤0.01% | 2091 |
|
|
2022
Q3 | $43K | Buy |
2,171
+407
| +23% | +$8.06K | ﹤0.01% | 2089 |
|
|
2022
Q2 | $31K | Hold |
1,764
| – | – | ﹤0.01% | 2290 |
|
|
2022
Q1 | $17K | Buy |
1,764
+919
| +109% | +$8.86K | ﹤0.01% | 2617 |
|
|
2021
Q4 | $14K | Hold |
845
| – | – | ﹤0.01% | 2779 |
|
|
2021
Q3 | $20K | Buy |
+845
| New | +$20K | ﹤0.01% | 2691 |
|